Vericel Corporation (VCEL)
NASDAQ·Healthcare·Biotechnology
$46.71
+2.74%
Mkt Cap $2.39B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$56.67
Range $46.00 – $70.00
Implied Upside
+21.3%
Consensus $56.67 vs current $46.71
NASDAQ·Healthcare·Biotechnology
$46.71
+2.74%
Mkt Cap $2.39B
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$56.67
Range $46.00 – $70.00
+21.3%
Consensus $56.67 vs current $46.71